<DOC>
	<DOCNO>NCT00668525</DOCNO>
	<brief_summary>This short-term study evaluate efficacy , safety , tolerability escitalopram adult patient ( 18 65 year age ) moderate severe depression . Patients complete study may eligible enter long-term open-label extension study escitalopram .</brief_summary>
	<brief_title>Escitalopram Adult Patients With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Patients must meet Diagnostic Statistical Manual , Fourth Edition , Text Revision ( DSMIVTR ) diagnostic criterion Major Depressive Disorder . The patient 's current depressive episode must least 8 week duration . Women pregnant , woman breastfeed study , woman childbearing potential practicing reliable method birth control . Patients history meeting DSMIVTR criterion : a. manic hypomanic episode ; b. schizophrenia psychotic disorder ; c. obsessivecompulsive disorder . Patients consider suicide risk Patients history seizure ( include seizure disorder ) , stroke , significant head injury , central nervous system tumor , condition predisposes patient risk seizure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Depression</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Escitalopram</keyword>
</DOC>